Cognitive Impairment Associated With Schizophrenia: Evaluating Emerging Therapies – Wednesday, January 15, 2025

Join us for a live-virtual CME lecture on schizophrenia!

Wednesday, January 15, 2025
1:00 PM – 2:00 PM EST

Course Information

PROVIDER STATEMENT

This activity is provided by Integrity CE, LLC.

DISCLOSURE OF COMMERCIAL SUPPORT

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

PROGRAM OVERVIEW

Cognitive impairment associated with schizophrenia (CIAS) is a core symptom domain of schizophrenia that can impose even greater long-term damage than the delusions and hallucinations this psychiatric disorder is known for. CIAS, which is marked by impairments in neurocognition and social cognition, can start in early childhood — long before any signs of psychosis. For many patients, functional outcomes are so compromised that performing activities of daily life and living independently are impossible.

Two therapies in late-phase development are showing promise in this symptom domain, with one being developed specifically for CIAS as an add-on treatment to standard-of-care antipsychotics. Join schizophrenia expert Daniel C. Javitt, MD, PhD for this presentation on emerging treatments for CIAS.

Learning Objectives

TARGET AUDIENCE

This activity addresses the needs of psychiatrists, psychiatry mental health therapists (eg, psychologists, social workers, case managers), nurse practitioners, physician assistants, pharmacists, primary care providers, and other clinicians involved in the management of patients with CIAS.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Characterize the disease burden and unmet treatment needs of patients with CIAS
  • Explain what is known about the pathophysiology of CIAS and how its symptoms differ from those in the negative domain
  • Select an emerging therapeutic agent for patients affected by CIAS based on safety, efficacy, and mechanism of action
Faculty Information and Disclosures

FACULTY

Daniel C. Javitt, MD, PhD
Professor and Director, Division of Experimental Therapeutics
Department of Psychiatry
Columbia University Irving Medical Center
New York, New York
Director, Schizophrenia Research
Nathan Kline Institute for Psychiatric Research
Orangeburg, New York

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Daniel C. Javitt, MD, PhD
Consultant: SK Life Sci
Speaker: Boehringer-Ingelheim

The Integrity CE, LLC planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. To receive credit, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • View the live broadcast
  • Complete the posttest evaluation form at the end of the program

A statement of credit will be issued only upon receipt of a completed posttest and activity evaluation form. Your certificate will be sent to you via email within four weeks of receipt of the completed evaluation.

ACCREDITATION STATEMENT

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Integrity CE, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)

Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS

Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:

Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Agenda

On the day of the webcast, you can access the Zoom meeting at this link: https://integrityce.com/CIAS8. A reminder email will be sent in the days prior to to the meeting with a pretest link; we ask that you please take the pretest prior to or at the beginning of the program.

There are no fees for participating and receiving CME credit for this activity. For your participation, you will be able to receive a maximum of 1.0 AMA PRA Category 1 CME Credit. To do so, you must complete the pretest, participate in the webcast, and complete the posttest and evaluation following the event. A statement of credit will be issued via email within four weeks of submission of a completed activity evaluation form.